62 Stocks Moving In Friday's Mid-Day Session

Gainers

• Marine Petroleum Trust MARPS shares jumped 121.5% to $5.45.
• Daseke, Inc. DSKE shares gained 24% to $6.43 after the company reported third-quarter earnings, well ahead of consensus estimates.
• Acadia Healthcare Company, Inc. ACHC climbed 20.3% to $34.87 after the company reported better-than-expected Q3 results and issued strong Q4 earnings guidance.
• MoneyGram International, Inc. MGI gained 19.1% to $5.35 after the company reported better-than-expected Q3 results.
• Rogers Corporation ROG gained 17.1% to $120.56 after the company reported better-than-expected Q3 results and issued strong Q4 guidance.
• MICT, Inc. MICT shares surged 17.1% to $3.01.
• Tricida, Inc. TCDA gained 14.4% to $4.9997. Tricida yesterday issued a regulatory update on veverimer, the only investigational asset in its pipeline.
• Air Industries Group AIRI gained 13.7% to $1.1745 after the company Reported Thursday that sales returned to pre-pandemic levels. Air Industries Group posted quarterly sales of $13.66 million.
• Cross Country Healthcare, Inc. CCRN surged 13.7% to $8.11. Cross Country Healthcare is expected to release quarterly earnings on November 4.
• Goosehead Insurance, Inc GSHD gained 13.6% to $121.64 following Q3 results.
• Ribbon Communications Inc. RBBN surged 13.2% to $4.37 after the company reported better-than-expected Q3 results.
• O2Micro International Limited OIIM jumped 12.7% to $6.12 after the company reported better-than-expected Q3 results.
• The9 Limited NCTY gained 12% to $2.32.
• Covanta Holding Corporation CVA surged 11.8% to $8.52 after the company reported better-than-expected Q3 results.
• Mohawk Industries, Inc. MHK gained 11.4% to $103.67 after the company reported better-than-expected Q3 results.
• DASAN Zhone Solutions, Inc. DZSI jumped 11.1% to $10.81 after the company reported better-than-expected Q3 results.
• Cleveland BioLabs, Inc. CBLI gained 9.1% to $2.9250.
• U.S. Xpress Enterprises, Inc. USX shares jumped 9.1% to $7.18.
• ResMed Inc. RMD gained 6.7% to $191.56 after the company reported better-than-expected Q1 results.
• Zendesk, Inc. ZEN rose 5.4% to $111.75 after the company reported better-than-expected Q3 results and also issued strong sales guidance .
• Newell Brands Inc NWL gained 5.2% to $17.69 after the company reported better-than-expected Q3 results. The company also reinstated guidance.
• Plantronics, Inc. PLT rose 4.8% to $19.90 after the company reported better-than-expected Q2 sales and also issued strong Q3 sales guidance.
• Equillium, Inc. EQ rose 4.7% to $6.28 after the company reported it received FDA clearance of COVID-19 IND for Phase 3 trial.
• Alphabet Inc. GOOG rose 4.1% to $1,630.94 following upbeat Q3 results.
• Under Armour Inc UA rose 3.3% to $12.43 after the company reported better-than-expected Q3 results and issued strong FY20 EPS guidance . The company also announced the sale of MyFitnessPal for $345 million.

Check out these big penny stock gainers and losers

Losers

• Bellicum Pharmaceuticals, Inc. BLCM shares dipped 39.2% to $3.5850 after the company priced its 4.15 million shares at $6.025 per share. Wells Fargo downgraded the stock from Overweight to Equal-Weight and announced a price target of $4.5 per share.
• Axovant Gene Therapies Ltd. AXGT fell 38.2% to $2.2550 after the company announced updates to be presented at its virtual Parkinson's disease R&D day, stating individual patient-level data from cohort 2 of the Phase 2 SUNRISE-PD study that is evaluating its AXO-Lenti-PD gene therapy for the treatment of Parkinson's disease showed favorable safety and tolerability profile, with no serious adverse events. The company also said it is unlikely that its planned sham-controlled trial of AXO-Lenti-PD will begin to enroll patients by the end of calendar year 2021.
• Intec Pharma Ltd. NTEC shares declined 24.3% to $2.33. Intec Pharma yesterday announced a 1-for-20 reverse share split.
• Universal Security Instruments, Inc. UUU shares fell 24% to $2.4864. Universal Security Instruments shares surged over 62% on Thursday after the company said it received a letter from 9.9% stakeholder Activist Investing threatening shareholder action to prevent delisting and bankruptcy.
• Pitney Bowes Inc. PBI fell 22.2% to $5.78 after the company reported Q3 earnings results.
• MicroVision, Inc. MVIS fell 19.9% to $1.77 after the company reported Q3 earnings results.
• OPKO Health, Inc. OPK fell 19.9% to $3.3656 after the company reported Q3 earnings results.
• Twitter, Inc. TWTR dipped 19.6% to $42.17. Twitter posted upbeat sales for its third quarter, while average daily active users rose just around 1 million from the previous quarter to 187 million last quarter.
• RAVE Restaurant Group, Inc. RAVE dipped 17.5% to $0.7181. Rave Restaurant announced the return of its contactless buffet to-go along with 3 new meals.
• HEXO Corp. HEXO shares fell 17.4% to $0.5941 after reporting Q4 results. The company reported a proposed 8-for-1 consolidation of common shares. The proposal will be submitted for approval on December 11th.
• Digital Turbine, Inc. APPS dropped 16.3% to $26.70 after reporting Q2 results.
• Columbia Sportswear Company COLM dropped 16.1% to $80.74 after the company reported worse-than-expected Q3 results. The company also issued weak Q4 forecast.
• Polar Power, Inc. POLA fell 16% to $3.11 after gaining over 58% on Thursday.
• HighPoint Resources Corporation HPR dropped 16% to $5.65. HighPoint Resources completed 1-for-50 reverse stock split.
• SQZ Biotechnologies Co SQZ shares dropped 15.8% to $13.48 after the company priced its IPO at $16 per share.
• Range Resources Corporation RRC dipped 15.4% to $6.57 following Q3 earnings.
• Cellect Biotechnology Ltd. APOP fell 15% to $1.77. Cellect Biotechnology shares jumped 22% on Thursday after the company commenced collaboration with XNK Therapeutics to advance novel NK cell-based therapies.
• Credit Acceptance Corporation CACC tumbled 14.5% to $272.60 after reporting downbeat quarterly sales.
• Bloom Energy Corporation BE fell 13.5% to $12.73 after the company reported worse-than-expected Q3 sales. Morgan Stanley maintained Bloom Energy with an Overweight and lowered the price target from $23 to $22.
• El Pollo Loco Holdings, Inc. LOCO fell 13.3% to $15.26 following weak quarterly sales.
• Data I/O Corporation DAIO dipped 13.2% to $3.4550 following wider-than-projected quarterly loss.
• Unity Software Inc. U fell 13% to $94.75.
• Seagen Inc. SGEN fell 12.5% to $168.32 after the company cut FY20 sales guidance
• Performance Shipping Inc PSHG shares fell 12.2% to $0.43 after the company reported a 1-for-10 reverse stock split.
• ZoomInfo Technologies Inc. ZI dropped 11.5% to $35.67.
• Evogene Ltd. EVGN fell 10.9% to $2.6450 as the company priced $12 million direct offering at $2.50 per share.
• Electro-Sensors, Inc. ELSE fell 10.6% to $3.6050 after gaining 7% on Thursday.
• Electrameccanica Vehicles Corp. SOLO fell 8.7% to $2.73 after gaining 20% on Thursday. ElectraMeccanica highlighted arrival of first production SOLO electric vehicles and opening of 6 new retail locations.
• Atlassian Corporation Plc TEAM fell 8.4% to $193.11 after the company reported Q1 results and issued weak Q2 EPS and sales guidance.
• Sunworks, Inc. SUNW fell 8.3% to $2.76 after climbing over 10% on Thursday.
• Pioneer Power Solutions, Inc. PPSI fell 8.2% to $2.70 after gaining over 14% on Thursday.
• Medigus ADR MDGS fell 8% to $2.29 after the company announced Purex will launch a Covid-19 product line on Amazon. Medigus previously signed an agreement to acquire a controlling stake in Purex.
• Marin Software Incorporated MRIN fell 7.6% to $2.42. Marin Software, earlier during the week, issued preliminary Q3 financial results.
• The Peck Company Holdings, Inc. PECK fell 7% to $6.69. The Peck Co, earlier during the month, announced $7.641 million in contracts from a 10.5MW portfolio of solar projects in Vermont..
• Avis Budget Group, Inc. CAR fell 6.4% to $34.34 after reporting a decline in quarterly earnings.
• Aptorum Group Limited APM fell 6.2% to $2.12 after gaining over 10% on Thursday.
• Apple Inc. AAPL fell 5% to $109.55. Apple announced better-than-expected results for its fiscal fourth-quarter. Apple's flagship product – the iPhone – fetched revenues of $26.44 billion, down 20.7%.